Subarachnoid hemorrhage (SAH) has a high mortality rate and causes long-term disability
in many patients, often associated with cognitive impairment. However, the pathogenesis of …

Subarachnoid hemorrhage (SAH) is an important cause of stroke mortality and morbidity,
especially in the young stroke population. Recent evidences indicate that neuroinflammation …

Subarachnoid hemorrhage (SAH) is a devastating cerebrovascular disorder. Neuro-
inflammation is a critical cause of brain injury following SAH in both acute and chronic …

Subarachnoid hemorrhage (SAH) is an important public health concern with high morbidity
and mortality worldwide. SAH induces cell death, blood− brain barrier (BBB) damage, brain …

The main reasons for disability and death in aneurysmal subarachnoid hemorrhage (aSAH)
may be early brain injury (EBI) and delayed cerebral ischemia (DCI). Despite studies …

Subarachnoid hemorrhage (SAH) can lead to devastating neurological outcomes, and there
are few pharmacologic treatments available for treating this condition. Both animal and …

Early brain injury (EBI) subsequent to subarachnoid hemorrhage (SAH) is strongly
associated with delayed cerebral ischemia and poor patient prognosis. Based on …

Background Inflammatory mechanism has been implicated in delayed cerebral ischemia
(DCI) and poor functional outcomes after subarachnoid hemorrhage (SAH). Identification of …

Aneurysmal subarachnoid hemorrhage (aSAH), with a crude worldwide incidence of around
7.9 per 100,000 person-years [1] and accounting for only 5% of all strokes, is a potentially …

Subarachnoid hemorrhage (SAH) is a devastating and complicated disease. The
development of therapeutic interventions has been hampered by a poor understanding of …